Gaize is an impairment detection technology that uses automated eye tests to identify current impairment from drugs including marijuana, alcohol, opiates, stimulants, and more. The system consists of a headset that captures high-precision ocular data and video evidence, analyzed by machine learning models to produce results in about 6 minutes. It is over 98% accurate and provides objective, defensible evidence of impairment. Gaize is designed for safety-sensitive workplaces and is 50-state legal in the US. It requires no body fluids and can reduce reliance on lab-based chemical testing, offering faster results at lower cost.
Key Features
- Broad spectrum detection: covers cannabis, alcohol, opioids, stimulants, dissociative anesthetics, and some psychedelics.
- Over 98% accuracy in clinical trials.
- Objective evidence with human-interpretable video.
- Fully automated, no expertise required.
- Results in real-time with downloadable reports.
Use Cases
- Workplace impairment screening for safety-sensitive industries.
- Post-incident testing and reasonable suspicion checks.
- Deterrent against on-the-job drug use.
Who It’s For
- Fortune 500s and small businesses.
- Safety directors and HR teams.
- Law enforcement agencies (separate product line).
Workflow
- Capture: The headset automatically records eye movement, pupil size, head movement, and other factors.
- Analyze: Data is processed by proprietary impairment detection models.
- Report: Results are stored and accessible from anywhere, with clear reporting.
Key Benefits
- Over 98% accurate at detecting impairment indicators
- Provides objective evidence with video recording